BioReliance (Merck)
Glasgow, UK · Rockville, MD
Hybrid — also manufactures internal programs
Program data pending ClinicalTrials.gov matching
· Last scored 2026-03-15
65.5
Signal Score
✓ FDA Inspections (1)
○ Clinical Trials
○ SEC Filings
○ Press
Quick Facts: BioReliance (Merck)
- Signal Score
- 65.5/100 (as of 2026-03-15)
- Quality Compliance
- Assessment pending
- Headquarters
- Glasgow, UK · Rockville, MD
- Modalities
- AAV, Lentiviral, Biologics
- Active CGT Programs
- No ClinicalTrials.gov matches confirmed
- Data Sources
- FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
- Scored By
- CDMO Signal — independent CGT manufacturing intelligence platform
Signal Score & Pillar Breakdown
Quality Compliance
—
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA Inspections1 on record
Warning Letters0
Last InspectionVoluntary Action Indicated (VAI) (2024-11-22)
Operations
—
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs
— no verified data
Sponsors— no verified data
ModalitiesAAV, Lentiviral, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Data sourced from ClinicalTrials.gov, FDA, SEC EDGAR, and verified press only. No unverified estimates shown.
Financial Stability
68.0
Parent company: Merck KGaA
Financial assessment: 68.0/100
Source: SEC EDGAR, press monitoring
Subsidiary of Merck KGaA
SEC FilingsParent: Merck KGaA
Parent company: Merck KGaA
Financial assessment: 68.0/100
Capacity
63.0
2 CGT manufacturing sites
Sites: Glasgow, UK, Rockville, MD
Source: SEC EDGAR, press monitoring, company profiles
2 CGT manufacturing sites
2 CGT manufacturing sites
FDA Inspection History
2024-11
NAI
VAI
OAI
| Date | Site | Type | Observations | Classification |
|---|---|---|---|---|
| 2024-11-22 | Rockville, Maryland | Vaccines and Allergenic Products | Yes | Voluntary Action Indicated (VAI) |
Source: FDA Data Dashboard · Retrieved Mar 20, 2026
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in: